Publications by authors named "K E Knox"

 There is a paucity of patient-reported outcomes (PROs) data in lower extremity salvage. Limb salvage can often be achieved with the use of local muscle flaps or fasciocutaneous flaps. The purpose of this study was to compare PROs of patients who underwent lower extremity salvage using local fasciocutaneous flaps or muscle flaps to lower extremity amputation.

View Article and Find Full Text PDF

Objectives: For individuals living with rare neurodevelopmental disorders, especially those who are at the most severe end of the spectrum, standardized outcome measures may lack the sensitivity to capture small but meaningful changes. Personalized endpoints such as Goal Attainment Scaling (GAS) allow the assessment of treatment response across variable baseline states and disease manifestations and thus provide a highly sensitive measure of efficacy. The current study tested the feasibility of using GAS in rare SCN2A-associated developmental and epileptic encephalopathy (SCN2A-DEE).

View Article and Find Full Text PDF

Background: The incidence of invasive fungal infections is increasing in immune-competent and immune-compromised patients. An examination of the recent literature related to the treatment of fungal infections was performed to address two clinical questions. First, in patients with proven or probable invasive pulmonary aspergillosis, should combination therapy with a mold-active triazole plus echinocandin be administered vs.

View Article and Find Full Text PDF
Article Synopsis
  • The text discusses California's Proposition 65, which aims to reduce consumer exposure to toxic chemicals by creating a list of harmful substances and discouraging businesses from using them.
  • The study evaluates national biomonitoring data to determine whether Prop 65 has successfully reduced exposure to these chemicals, focusing on changes in blood and urine concentrations among participants over time.
  • Results indicate that while the concentration of listed chemicals like Bisphenol A (BPA) declined, some non-listed but related chemicals (like Bisphenol S) increased, suggesting businesses may be substituting one harmful chemical for another.
View Article and Find Full Text PDF